Aurinia Pharmaceuticals Inc. (AUPH)

Aurinia Pharmaceuticals Revenue

Aurinia Pharmaceuticals had revenue of $83.70M in the quarter ending September 30, 2026, with 13.93% growth. This brings the company's total for the last twelve months to $297.09M, up 20.16% year-over-year. In the year 2025, Aurinia Pharmaceuticals had annual revenue of $283.06M with 20.38% growth. That makes Aurinia Pharmaceuticals the 14,035th largest company in the world by revenue and 2,572nd in the United States.

• Revenue (ttm): $297.09M
• Revenue Growth: +20.16%
• P/S Ratio: 6.86
• Revenue / Employee: $2,513,578
• Employees: 128
• Market Cap: 2.21B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• United States 263.84M 93.2%
• Japan 19.21M 6.8%

Fiscal year ended Dec 31, 2025 See the full Aurinia Pharmaceuticals breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	283.06M	47.92M	20.38%
Dec 31, 2024	235.13M	59.62M	33.97%
Dec 31, 2023	175.51M	41.48M	30.95%
Dec 31, 2022	134.03M	88.43M	193.89%
Dec 31, 2021	45.61M	-4.51M	-9.00%
Dec 31, 2020	50.12M	49.80M	15,660.38%
Dec 31, 2019	318.00K	-145.00K	-31.32%
Dec 31, 2018	463.00K	45.00K	10.77%
Dec 31, 2017	418.00K	245.00K	141.62%
Dec 31, 2016	173.00K	-1.00M	-85.29%
Dec 31, 2005	1.18M	-	-

Data Sources: Fiscal.ai and S&P Global Market Intelligence Last updated: Oct 30, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company. Revenue geography data is provided by S&P Global Market Intelligence.

Update frequency:

Quarterly

Last checked:

Nov 5, 2026

Data Sources Report a data error